Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  BOC-amino acid >  Boc-L-2,4-diaminobutyric acid

Boc-L-2,4-diaminobutyric acid

Basic information Safety Supplier Related

Boc-L-2,4-diaminobutyric acid Basic information

Product Name:
Boc-L-2,4-diaminobutyric acid
Synonyms:
  • 2-amino-4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]butanoic acid
  • BOC-ALPHA,GAMMA-DIAMINOBUTYRIC ACID
  • BOC-L-DAB-OH
  • BOC-DAB-OH
  • BOC-L-2,4-DIAMINOBUTYRIC ACID
  • N-ALPHA-T-BUTOXYCARBONYL-L-ALPHA, GAMMA-DIAMINOBUTYRIC ACID
  • N-ALPHA-T-BUTYLOXYCARBONYL-L-2,4-DIAMINOBUTYRIC ACID
  • N-ALPHA-TERT-BUTYLOXYCARBONYL-L-2,4-DIAMINOBUTYRIC ACID
CAS:
25691-37-6
MF:
C9H18N2O4
MW:
218.25
EINECS:
624-609-1
Product Categories:
  • pharmacetical
  • Amino Acids & Deriv.
  • CHIRAL CHEMICALS
Mol File:
25691-37-6.mol
More
Less

Boc-L-2,4-diaminobutyric acid Chemical Properties

Melting point:
192-194 °C
Boiling point:
385.5±37.0 °C(Predicted)
Density 
1.160±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
Methanol (Sparingly), Water (Slightly)
form 
Powder
pka
3?+-.0.10(Predicted)
color 
White to off-white
optical activity
[α]/D +7.5±1°, c = 1 in methanol: water (1:1)
BRN 
4745487
CAS DataBase Reference
25691-37-6(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
38-41
Safety Statements 
26-39
RIDADR 
3265
WGK Germany 
3
HS Code 
2922.49.8000
HazardClass 
8
PackingGroup 
More
Less

Boc-L-2,4-diaminobutyric acid Usage And Synthesis

Uses

Boc-L-2,4-diaminobutyric acid is a reagent used to synthesize somatostatin antagonist. It can also be used to develop blood coagulation factor Xa inhibitors.

Synthesis

13726-85-7

25691-37-6

General procedure for the synthesis of (S)-4-amino-2-((tert-butoxycarbonyl)amino)butanoic acid from BOC-L-glutamine: to a mixed solution of (S)-5-amino-2-(tert-butoxycarbonylamino)-5-oxopentanoic acid (2 g, 8.1 mmol) in DMF and water (1:1, v/v, 18 ml) was added pyridine (1.3 ml, 16.2 mmol). The reaction mixture was stirred at room temperature for 5-10 min. Subsequently, iodobenzene diacetate (3.92 g, 12.1 mmol) was added and the reaction was continued with stirring for 4 hours. After completion of the reaction, deionized water (100 ml) was added to the reaction mixture and extracted with ethyl acetate (3 x 100 ml). The organic phases were combined and washed sequentially with deionized water (100 ml) and saturated saline (100 ml), dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain the crude product. The crude product was purified by ether milling and after evaporation of the product grades, 1.1 g (62% yield) of the target compound was obtained as a brown solid. LC-MS analysis showed m/z = 219.1 (M + H).

References

[1] Synthetic Communications, 2004, vol. 34, # 6, p. 1049 - 1056
[2] Journal of Medicinal Chemistry, 2009, vol. 52, # 15, p. 4650 - 4656
[3] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
[4] Patent: WO2014/151472, 2014, A1. Location in patent: Paragraph 00340-00341
[5] Patent: WO2016/40315, 2016, A1. Location in patent: Paragraph 00383; 00384

Boc-L-2,4-diaminobutyric acidSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com